[DOI] [PubMed] [Google Scholar] 124.Gullaksen S, Vernstrom L, Sorensen SS, Ringgaard S, Laustsen C, Funck KL, et al
They designated these glucagon-like peptides 1 & 2 (GLP-1 and GLP-2) because their sequences bore a strong similarity to glucagon
Contact Dermatitis 71, 191201 (2014)
accordingly, choosing an appropriate course of therapy is more difficult
Now, amidst growing controversy, a federal judge has taken the FDAs stance one step further and has ordered Flawless Beauty, a New Jersey company selling unapproved skin-whitening products (including skin-lightening injections), to stop distributing its due to serious health risks associated with the injections
This matters because a polished thumbnail, label, or vendor page can make a product feel more established than it is